Valuation: Bayer AG

Market Cap 4.92TCr 5.63TCr 4.54TCr 4.19TCr 7.96TCr 5,36900Cr 8.09TCr 54TCr 21TCr 2,64500Cr 21TCr 21TCr 9,09200Cr P/E 2026 *
21.2x
P/E 2027 * 15.9x
Enterprise Value 8.1TCr 9.26TCr 7.47TCr 6.9TCr 13TCr 8,83000Cr 13TCr 89TCr 35TCr 4,35000Cr 35TCr 34TCr 14,95500Cr EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.67x
Free-Float
100%
Yield 2026 *
0.47%
Yield 2027 * 1.27%
1 week-3.93%
Current month+7.03%
1 month+45.30%
3 months+24.42%
6 months+31.20%
Current year+41.50%
1 week 216
Extreme 216
226.7
1 month 149.9
Extreme 149.9
230.5
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 66 01/04/2022
Director/Board Member 60 01/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-3.93%+85.05%-4.72% 5.63TCr
-2.33%-2.09%+49.88%+169.76% 1,06000Cr
-0.82%-2.30%+63.79%+62.56% 62TCr
-0.73%-4.98%+28.91%+83.79% 44TCr
-0.06%+1.42%+30.58%+25.75% 33TCr
+0.05%-0.58%+28.98%+47.02% 28TCr
-0.71%-9.66%+19.47%+23.31% 27TCr
+0.19%+0.56%-27.15%-38.25% 22TCr
-0.06%-2.88%+23.07%+61.02% 20TCr
-3.72%-1.10%+18.41%+69.98% 16TCr
Average -0.91%-3.33%+32.10%+50.02% 39.71TCr
Weighted average by Cap. -1.14%-3.10%+37.16%+82.10%

Financials

2026 *2027 *
Net sales 4.56TCr 5.21TCr 4.2TCr 3.88TCr 7.36TCr 4,96700Cr 7.49TCr 50TCr 20TCr 2,44700Cr 20TCr 19TCr 8,41200Cr 4.67TCr 5.33TCr 4.3TCr 3.97TCr 7.54TCr 5,08700Cr 7.67TCr 51TCr 20TCr 2,50600Cr 20TCr 20TCr 8,61500Cr
Net income 214.58Cr 245.32Cr 197.92Cr 182.8Cr 346.86Cr 23TCr 352.7Cr 2.36TCr 928.69Cr 12TCr 921.11Cr 901.06Cr 40TCr 299.22Cr 342.09Cr 276Cr 254.91Cr 483.68Cr 33TCr 491.82Cr 3.3TCr 1.3TCr 16TCr 1.28TCr 1.26TCr 55TCr
Net Debt 3.17TCr 3.63TCr 2.93TCr 2.7TCr 5.13TCr 3,46200Cr 5.22TCr 35TCr 14TCr 1,70500Cr 14TCr 13TCr 5,86200Cr 2.85TCr 3.26TCr 2.63TCr 2.43TCr 4.61TCr 3,11100Cr 4.69TCr 31TCr 12TCr 1,53200Cr 12TCr 12TCr 5,26800Cr
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
13/26/13 PLN 216.00 -0.83%
10/26/10 PLN 217.80 0.00%
09/26/09 PLN 217.80 0.00%
08/26/08 PLN 217.80 0.00%
07/26/07 PLN 217.80 -3.93%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
50.12EUR
Average target price
54.28EUR
Spread / Average Target
+8.30%

Quarterly revenue - Rate of surprise